Authors


Justin M. Gregory, MD, MSC

Latest:

Bridging the Gap for T1D Management

Expert endocrinologists provide final thoughts on addressing unmet needs and improving the management of T1D.



Priya Bansal, MD

Latest:

Future Landscape of BTK Inhibitors for CSU

Panelists discuss the current and future roles of advanced treatments, including biologics and Bruton tyrosine kinase (BTK) inhibitors, in the management of chronic spontaneous urticaria (CSU), highlighting their potential to improve patient outcomes and the evolving landscape of treatment options.


Killian Meara

Latest:

China Hits 1 Billion COVID-19 Vaccines Administered

Africa sees third wave as only 1% of the population is fully vaccinated.


Barry A. Borlaug, MD | Image Credit: Mayo Clinic
Barry A. Borlaug, MD

Latest:

Barry A. Borlaug, MD: Impact of Tirzepatide on Cardiorenal End-Organ Damage in HFpEF

Barry A. Borlaug, MD describes the beneficial effect of tirzepatide on circulatory pressure-volume overload and end-organ damage in patients with HFpEF and obesity.


Morgan Petronelli

Latest:

FDA Approves Fezolinetant for Moderate to Severe Hot Flashes in Menopause

Announced on May 12, 2023, the FDA's approval of fezolinetant (Veozah) marks their first approval for an NK3 receptor antagonist for the treatment of vasomotor symptoms of menopause.


Matthew J. Budoff, MD

Latest:

Future Directions for the Treatment of ASCVD and Hypercholesterolemia

Drs Paul S. Jellinger, Erin D. Michos, Matthew J. Budoff, Christie Ballantyne, and Yehuda Handelsman share closing thoughts and advice for the management of ASCVD and hypercholesterolemia.


Christie Ballantyne, MD

Latest:

Clinical Pearls on Lipid Management

A panel of expert cardiologists share their clinical pearls for managing patients with hyperlipidemia.


Robert J. Mentz, MD

Latest:

Clinical Pearls for the Treatment of Heart Failure

Drs James Januzzi, Javed Butler, Robert Mentz, and Muthiah Vaduganathan share practice pearls for treating patients with heart failure, focusing on the future of treatment.


Patrick McGann, MD, MS, Cincinnati Children’s Hospital

Latest:

What’s Next and Final Thoughts in SCD

Experts look into what is next for sickle cell disease and provide key thoughts on the space.


Raj Chovatiya, MD, PhD

Latest:

Future Outlook for Atopic Dermatitis Treatments

Medical experts share their final thoughts on the future of atopic dermatitis treatment with oral systemic agents.



Manesh R. Patel, MD

Latest:

Looking Into the Future of Lipid Management

Dr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia


Joseph Reilly, BS, PharmD, BCGP

Latest:

Key Takeaways on FMTs in the Treatment of CDI

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.


Honey East, MD

Latest:

Long-Term Outcomes for Patients Treated for Hypercortisolism

The panel concludes by discussing the long-term outcomes for patients treated for hypercortisolism, emphasizing the need for further studies and data, and sharing their final thoughts on the disease and its future management.


Lady Katherine Mejía Pérez, MD

Latest:

Celiac Disease ACG Guidelines Update

An expert reviews the updated recommendations of the American College of Gastroenterology guidelines on the evaluation and management of celiac disease.


Erin Boh, MD, PhD, FAAD

Latest:

Future Directions in the Treatment of Plaque Psoriasis

Key opinion leaders conclude their discussion on plaque psoriasis by commenting on the potential for research into the genetic origin of disease, possible biomarkers, and treatment options with greater efficacy.


Chee Kay Cheung, MBCHB, MRCP, PhD

Latest:

Future of IgAN Treatment and Clinical Pearls for Disease Management

Cheung comments on new and future IgAN treatment, and shares clinical pearls with other providers.


Scott Kahan, MD, MPH

Latest:

Updates in the Standards of Care in Diabetes in 2023 - Obesity and Weight Management

Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES, interview Scott Kahan, MD, MPH who serves on the committee that creates the ADA Standards of Care in Diabetes, to discuss the latest updates in weight management guidelines.


Matthew Brunner, PA

Latest:

Practice Pearls for the Management of Atopic Dermatitis

Alexa Hetzel, MA, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, PA, share practice pearls and clinical management tips for the care of pediatric patients with atopic dermatitis.


Gerald B. Appel, MD

Latest:

Clinical trial data on IgAN for therapies

Gerald B. Appel, MD, discusses the changing treatment landscape of IgAN.



Theresa R. Cerulli, MD

Latest:

Final Thoughts on Management of ADHD

ADHD experts share their final thoughts on the treatment and management of ADHD.


Samuel Nordberg, PhD

Latest:

Optimizing the Management of TRD

An expert panel shares insight on the future treatment landscape for treatment-resistant depression.


David Brown, MD

Latest:

Perspectives on the Future of Retinal Disease Management

Experts conclude this series highlighting what is on the horizon of retinal disease care.


James Williams, MS, DO, FACEP

Latest:

Discharge Planning and Transition of Care in HE

Drs Arun Jesudian and James William discuss approaches for proper discharge planning and transition of care and how this can reduce readmission for patients with hepatic encephalopathy.


Jay Shubrook, DO, FACOFP, FAAFP, BC-ADM, Touro University California College of Osteopathic Medicine

Latest:

Final Thoughts: Awareness and Communication in Diabetes

Thought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers. 


Robert Sporter, MD

Latest:

Advice for Clinicians Managing Asthma

The panel offers their final recommendations for physicians managing patients with asthma.


Biree Andemariam, MD

Latest:

Practice Pearls for the Management of SCD

A panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.


Deepak Bhatt, MD, MPH, MBA

Latest:

Cardiometabolic Medicine: Seeing the Patient as a Whole

The panelists stress the significance of a comprehensive approach to patient care, acknowledging the interconnected nature of cardiovascular, kidney, endocrine, and obesity-related benefits, and highlighting that addressing secondary diseases can minimize overall disease risk in patients.

© 2024 MJH Life Sciences

All rights reserved.